DRACP ID | Peptide Name | Sequence | Sequence Length | C terminal |
---|---|---|---|---|
DRACP00362 | HAL-1/17 | KMWSKILGHLIR | 12 | Amidation |
DRACP00363 | LL-III/22 | KNWKKXLKKXIKXVK | 15 | Amidation |
DRACP00364 | LL-III/10 | KNWKKILGKIIKVVK | 15 | Amidation |
DRACP00365 | LL-III/18 | KNWKKILKKIIKVVK | 15 | Amidation |
DRACP00366 | MAC1/3 | LFGMALKLLKKVL | 13 | Amidation |
DRACP00367 | LL-III/34 | NKWKKILGKIIKVVK | 15 | Amidation |
DRACP00368 | LL-III/2 | NVWKKILGKIIKVVK | 15 | Amidation |
DRACP00369 | LL-III/15 | VNFKKLLGKLLKVVK | 15 | Amidation |
DRACP00370 | LL-III/16 | VNXKKLLGKLLKVVK | 15 | Amidation |
DRACP00371 | LL-III/19 | VNWKKXLGKXIKXVK | 15 | Amidation |
DRACP00372 | LL-III/11 | VNWKKIILGKIIKVVK | 16 | Amidation |
DRACP00373 | LL-III/1 | VNWKKILAKIIKVVK | 15 | Amidation |
DRACP00374 | LL-III/36 | VNWKKILAKIIKVVK | 15 | Amidation |
DRACP00375 | LL-III | VNWKKILGKIIKVVK | 15 | Amidation |
DRACP00376 | LL-III/12 | vnwkkilgkiikvvk | 15 | Amidation |
DRACP00377 | LL-III/37 | VNWKKVLAKIIKVVK | 15 | Amidation |
DRACP00378 | LL-III/8 | VNWKKILGKIIKVVK | 15 | Free |
DRACP00379 | LL-III/9 | VNWKKILGKIIKVVK | 15 | Methylester (OMe) |
DRACP00380 | LL-III/4 | VNWKKILGKIKKVVK | 15 | Amidation |
DRACP00381 | LL-III/3 | VNWKKILKKIIKVVK | 15 | Amidation |
DRACP00382 | LL-III/6 | VNWKKILPKIIKVVK | 15 | Amidation |
DRACP00383 | LL-III/23 | VNWKKLLGKLLKVVK | 15 | Amidation |
DRACP00384 | Cathelicidin-1, CATH-1, Fowlicidin-1 | RVKRVWPLVIRTVIAGYNLYRAIKKK | 26 | Free |
DRACP00385 | LL-III/25 | vnwkkllgkllkvvk | 15 | Amidation |
DRACP00386 | LL-III/27 | VNWKKVLGKVVKVVK | 15 | Amidation |
DRACP00387 | LL-III/24 | VNWXXILGXIIXVVX | 15 | Amidation |
DRACP00388 | LL-III/17 | VNWRRILGRIIRVVR | 15 | Amidation |
DRACP00389 | Cecropin-B | KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL | 35 | Amidation |
DRACP00390 | LL-III/26 | VYWKKILGKIIKVVK | 15 | Amidation |
DRACP00391 | SVS-1 | KVKVKVKVpPTKVKVKVK | 18 | Free |